Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class

EU orphan designation number: EU/3/08/605   
Active ingredient: Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class
Indication: Treatment of spinal cord injury
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2009 Centralised Orphan - Designation EMEA/OD/059/08 (2009)387 of 19/01/2009
29/08/2014 Centralised Orphan - Change of address